Breaking News

TransCelerate, Cognizant Enter Clinical Trials Platform Pact

Aims to improve collaboration between clinical sites and pharma companies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Cognizant has been selected by TransCelerate BioPharma Inc., a non-profit organization representing members from 19 pharma companies, to develop a new subscription-based platform aimed at improving collaboration between clinical sites and pharma companies. TransCelerate is dedicated to making the R&D process more efficient across the pharma industry.                                                                                                      The Shared Investigator Platform will be b...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters